These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10354193)

  • 1. Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty.
    Wallner S; Watzinger N; Lindschinger M; Smolle KH; Toplak H; Eber B; Dittrich P; Elmadfa I; Klein W; Krejs GJ; Wascher TC
    Eur J Clin Invest; 1999 May; 29(5):372-9. PubMed ID: 10354193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter randomized trial. Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators.
    JAMA; 1997 Mar; 277(9):715-21. PubMed ID: 9042843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty.
    Mark DB; Nelson CL; Califf RM; Harrell FE; Lee KL; Jones RH; Fortin DF; Stack RS; Glower DD; Smith LR
    Circulation; 1994 May; 89(5):2015-25. PubMed ID: 8181125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent ischemia more than 1 year after successful percutaneous transluminal coronary angioplasty. An analysis of the extent and anatomic pattern of coronary disease.
    Bottner RK; Green CE; Ewels CJ; Recientes E; Patrissi GA; Kent KM
    Circulation; 1989 Dec; 80(6):1580-4. PubMed ID: 2598421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
    Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
    Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery.
    Stephan WJ; O'Keefe JH; Piehler JM; McCallister BD; Dahiya RS; Shimshak TM; Ligon RW; Hartzler GO
    J Am Coll Cardiol; 1996 Nov; 28(5):1140-6. PubMed ID: 8890807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI).
    Whitlow PL; Dimas AP; Bashore TM; Califf RM; Bourassa MG; Chaitman BR; Rosen AD; Kip KE; Stadius ML; Alderman EL
    J Am Coll Cardiol; 1999 Nov; 34(6):1750-9. PubMed ID: 10577566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical therapy after successful percutaneous coronary revascularization.
    Hasdai D; Lerman A; Grill DE; Rihal CS; Holmes DR
    Ann Intern Med; 1999 Jan; 130(2):108-15. PubMed ID: 10068356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES).
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Vatne K; Hansen J; Webb J; Buller C; Goulet G; Erikssen J; Thaulow E
    J Am Coll Cardiol; 2000 Mar; 35(3):592-9. PubMed ID: 10716459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
    Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
    Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease.
    Lauer B; Junghans U; Stahl F; Kluge R; Oesterle SN; Schuler G
    J Am Coll Cardiol; 1999 Nov; 34(6):1663-70. PubMed ID: 10577553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cholesterol, lifestyle, working capacity and quality of life in patients with coronary artery disease. Experiences from a hospital-based secondary prevention programme.
    Carlsson R
    Scand Cardiovasc J Suppl; 1998; 50():1-20. PubMed ID: 9802147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.
    Wilson JM; Ferguson JJ
    Tex Heart Inst J; 1995; 22(2):145-61. PubMed ID: 7647598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients.
    Rinehart AL; Herzog CA; Collins AJ; Flack JM; Ma JZ; Opsahl JA
    Am J Kidney Dis; 1995 Feb; 25(2):281-90. PubMed ID: 7847356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up after percutaneous transluminal coronary angioplasty in patients with single-vessel disease.
    Kadel C; Vallbracht C; Buss F; Kober G; Kaltenbach M
    Am Heart J; 1992 Nov; 124(5):1159-69. PubMed ID: 1442481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five- to ten-year outcome after multivessel percutaneous transluminal coronary angioplasty.
    Le Feuvre C; Bonan R; Côté G; Crépeau J; De Guise P; Lespérance J; Théroux P
    Am J Cardiol; 1993 May; 71(13):1153-8. PubMed ID: 8480639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? Multivessel Angioplasty Prognosis Study (MAPS) Group.
    Cowley MJ; Vandermael M; Topol EJ; Whitlow PL; Dean LS; Bulle TM; Ellis SG
    J Am Coll Cardiol; 1993 Nov; 22(5):1289-97. PubMed ID: 8227782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Circulation; 1992 Jul; 86(1):100-10. PubMed ID: 1535568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five years of angiographic and clinical follow-up after successful percutaneous transluminal coronary angioplasty.
    Guiteras P; Tomas L; Varas C; Augé JM; Masotti M; Crexells C; Oriol A
    Eur Heart J; 1989 Dec; 10 Suppl G():42-8. PubMed ID: 2627948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary artery angioplasty: delayed resolution of exercise-induced scintigraphic abnormalities.
    Manyari DE; Knudtson M; Kloiber R; Roth D
    Circulation; 1988 Jan; 77(1):86-95. PubMed ID: 2961482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.